Synthesis and biological evaluation of isoliquiritigenin derivatives as a neuroprotective agent against glutamate mediated neurotoxicity in HT22 cells. 2020

Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
Convergence Research Center for Dementia, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; Natural Product Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea; Division of Bio-medical Science & Technology, University of Science and Technology, Daejun 34113, Republic of Korea.

Glutamate-induced neurotoxicity is characterized by cellular Ca2+ uptake, which is upstream of reactive oxygen species (ROS)-induced apoptosis signaling and MAPKs activation. In the present study, we synthesized isoliquiritigenin analogs with electron-donating and electron-withdrawing functional groups. These analogs were evaluated for neuroprotective effect against glutamate-induced neurotoxicity in HT22 cells. Among these analogs, compound BS11 was selected as a potent neuroprotective agent. Cellular Ca2+ concentration, ROS level, MAPKs activation and AIF translocation to the nucleus were increased upon treatment with 5 mM glutamate. In contrast, we identified that compound BS11 reduced the cellular Ca2+ concentration and ROS level upon glutamate exposure. Western blot analysis showed that MAPK activation was decreased by treatment with compound BS11. We further identified that cotreatment of compound BS11 and glutamate inhibited translocation of AIF to the nucleus.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D047188 Chalcones Derivatives of CHALCONE that are important intermediates in the formation of FLAVONOIDS with anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties. 1,3-Diphenyl-propanediones,1,3-Diphenyl-propenones,1,3-Diphenylpropanediones,1,3-Diphenylpropenones,Chalconoids,1,3 Diphenyl propanediones,1,3 Diphenyl propenones,1,3 Diphenylpropanediones,1,3 Diphenylpropenones
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
December 2016, Bioorganic & medicinal chemistry letters,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
May 2016, Bioorganic & medicinal chemistry letters,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
December 2019, Molecules (Basel, Switzerland),
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
September 2018, Neurotoxicology,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
March 2012, Bioorganic & medicinal chemistry letters,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
April 2017, BMC complementary and alternative medicine,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
June 2012, Archiv der Pharmazie,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
September 2009, European journal of pharmacology,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
October 2019, RSC advances,
Baskar Selvaraj, and Dae Won Kim, and Gyuwon Huh, and Heesu Lee, and Kyungsu Kang, and Jae Wook Lee
April 2015, Drug and chemical toxicology,
Copied contents to your clipboard!